Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03384680
Other study ID # KCRD_Lung cancer_Symptoms
Secondary ID
Status Recruiting
Phase N/A
First received December 20, 2017
Last updated January 5, 2018
Start date September 16, 2015
Est. completion date May 31, 2018

Study information

Verified date January 2018
Source Kyunghee University Medical Center
Contact Chunhoo Cheon
Phone 02-961-9278
Email pm.thehoo@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is conducted to collect the symptoms of lung cancer patients and to observe the relationship with proteomics.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 31, 2018
Est. primary completion date March 31, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult over 18 years old

- Patients are scheduled for surgery with lung cancer diagnosis.

- ECOG status score 0 to 2

- Individual who can read and understand Korean

- Participant is willing and able to give informed consent for participation in the study

Exclusion Criteria:

- Patient who was diagnosed with lung cancer in the past.

- Individuals who are judged inappropriate for the study

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Korea University Guro Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seong-Gyu Ko

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pattern identification Pattern identification by Body constitution questionnaire(BCQ) BCQ(+) is a questionnaire that is comprised of nineteen questions with one-to-five rating scales, making the range of total score to be between nineteen and ninety-five points with the cut-off score of 30.5 points for Yang-Xu.
BCQ(-) is composed of another set of nineteen questions with the same five-point Likert scales, with the cut-off score of 29.5 points for Yin-Xu.
BCQ(s) consists of twenty-three questions with the same Likert scale cut-off score of 26.5 points for Stasis.
For 1 year
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk